Enhancing spectroscopy analysis with machine learning
03 February 2025
The spectroscopy-based study highlights the importance of integrating data-driven approaches to enhance isomer discrimination.
The production of new Russian “super antibiotic” to begin in Novosibirsk
03 February 2025
The Vorozhtsov Novosibirsk Institute of Organic Chemistryis launching the preparatory phase for the production of an innovative antibiotic, Fluorothiazinone, developed by researchers at the Gamaleya National Research Center for Epidemiology and Microbiology. According to Pavel Zaikin, head of the Institute’s Engineering Center, they are already manufacturing the drug’s key component.
A Russian company has started producing 4 veterinary vaccines
31 January 2025
A Russian enterprise has launched the production of four veterinary vaccines. The federal state enterprise “Shchelkovo Biochemical Plant” has expanded its range of domestic veterinary drugs by starting the production of several vaccines for livestock.
The government held its first meeting on the “New technologies for preserving health” project
31 January 2025
At the first meeting of the project committee for the national project “New Health Preservation Technologies,” chaired by Deputy Prime Minister Tatyana Golikova, key areas for state support of medical innovations were identified. The government plans to invest in the development of advanced methods for diagnosing biological age and technologies for slowing cellular aging.
Enhancing spectroscopy analysis with machine learning
30 January 2025
The spectroscopy-based study highlights the importance of integrating data-driven approaches to enhance isomer discrimination.
A device for chronic pain relief has been registered in Russia
30 January 2025
Motorika Nemo has completed the registration procedure for a spinal cord stimulation (SCS) device complex from the Chinese manufacturer Rishena. The complex includes an implantable stimulator, a programmer-charger, an external test stimulator, and a specialized electrode with accessories.
East Asians underrepresented in biopharma C-suites: report
29 January 2025
Despite making up a sizable chunk of entry-level employees at the biggest U.S. biopharmas, the share of east Asian Americans drops dramatically as you move up the ranks. That’s according to a report from ElevAAte Biotech, a new nonprofit that seeks to boost the biopharma C-suite representation of Americans who come from countries like China, Japan, South Korea and Taiwan.
Russia to begin testing individual mRNA vaccines against cancer in September
29 January 2025
In September 2025, the Russian personalized mRNA vaccine will be used in an experimental mode. The Ministry of Health’s permission is expected in August, but the plan is still awaiting approval.
Biologic demonstrates “tremendous” potential advance in atrial fibrillation
28 January 2025
The Phase II study validated an “incredibly safe bleeding profile” for Factor XI inhibitors as a treatment for the common cardiovascular condition.
The number of veterinary drug importers has risen by 38% since labeling began
28 January 2025
Following the implementation of the mandatory labeling system for veterinary drugs in Russia, there has been a notable rise in the number of companies engaged in import activities, according to Revaz Yusupov, Deputy General Director of the Center for the Development of Advanced Technologies (CRPT), which operates the digital labeling system “Honest Sign.”
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
Enhancing spectroscopy analysis with machine learning
03 February 2025
The production of new Russian “super antibiotic” to begin in Novosibirsk
03 February 2025
A Russian company has started producing 4 veterinary vaccines
31 January 2025
The government held its first meeting on the “New technologies for preserving health” project
31 January 2025